Difficulty: Medium
Average Score: 71%
Practice
A challenge faced with antiretroviral therapy (ART) is:
Correct answer
B
Rationale
Drug-resistant mutations of HIV are a major challenge in antiretroviral therapy (ART) due to the virus's high mutation rate, driven by its error-prone reverse transcriptase. Incomplete adherence missing doses or irregular intake creates suboptimal drug levels, allowing HIV to replicate and select for resistant strains. These mutations (e.g., M184V for lamivudine) can render first-line drugs like zidovudine ineffective, necessitating complex, costly regimens with greater side effects, as seen in studies like those in Clinical Infectious Diseases. Option A, 'patients abusing ART,' misrepresents the issue ART drugs lack recreational appeal; non-adherence, not abuse, drives resistance. Option C, 'reduction of transmissibility,' is a benefit, not a challenge viral suppression via ART cuts transmission risk by over 90% (HPTN 052 trial). Option D, 'lack of efficacy data,' is false; extensive trials (e.g., supporting dolutegravir) provide robust evidence. Resistance, rooted in virologic and behavioral factors, demands strict adherence and monitoring, making B the clear, evidence-backed answer.